Tolerance to lipopolysaccharide promotes an enhanced neutrophil extracellular traps formation leading to a more efficient bacterial clearance in mice by Landoni, Verónica Inés et al.
Tolerance to lipopolysaccharide promotes an enhanced neutrophil
extracellular traps formation leading to a more efficient bacterial
clearance in micecei_4560 153..163
V. I. Landoni,* P. Chiarella,*
D. Martire-Greco,* P. Schierloh,*
N. van-Rooijen,† B. Rearte,*
M. S. Palermo,* M. A. Isturiz* and
G. C. Fernández*
*Immunology Department of the Instituto de
Medicina Experimental (IMEX, CONICET) and
Academia Nacional de Medicina de Buenos Aires,
Argentina, and †Department of Molecular Cell
Biology, Vrije University Medical Center,
Amsterdam, the Netherlands
Summary
Tolerance to lipopolysaccharide (LPS) constitutes a stress adaptation, in
which a primary contact with LPS results in a minimal response when a
second exposure with the same stimulus occurs. However, active important
defence mechanisms are mounted during the tolerant state. Our aim was to
assess the contribution of polymorphonuclear neutrophils (PMN) in the
clearance of bacterial infection in a mouse model of tolerance to LPS. After
tolerance was developed, we investigated in vivo different mechanisms of
bacterial clearance. The elimination of a locally induced polymicrobial chal-
lenge was more efficient in tolerant mice both in the presence or absence of
local macrophages. This was related to a higher number of PMN migrating to
the infectious site as a result of an increased number of PMN from the
marginal pool with higher chemotactic capacity, not because of differences in
their phagocytic activity or reactive species production. In vivo, neutrophils
extracellular trap (NET) destruction by nuclease treatment abolished the
observed increased clearance in tolerant but not in control mice. In line with
this finding, in vitro NETs formation was higher in PMN from tolerant
animals. These results indicate that the higher chemotactic response from an
increased PMN marginal pool and the NETs enhanced forming capacity are
the main mechanisms mediating bacterial clearance in tolerant mice. To sum
up, far from being a lack of response, tolerance to LPS causes PMN priming
effects which favour distant and local anti-infectious responses.
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Introduction
Lipopolysaccharide (LPS) is the main component of the
cell membrane of Gram-negative microorganisms and is an
important cause of the sepsis syndrome [1,2]. LPS is a potent
stimulator of the release of proinflammatory cytokines asso-
ciated with septic shock. In experimental models, the inocu-
lation of high doses of LPS induces pathological symptoms
similar to those observed in the inflammatory phase of septic
shock. However, exposure to repetitive low concentrations
of LPS generates a refractory state towards its effects, known
as tolerance to LPS [3]. Interestingly, tolerant cells or whole
organisms can withstand a challenge of LPS with a concen-
tration many times above that necessary to stimulate cells or
to cause death. Tolerance has been postulated as a protective
mechanism limiting excessive inflammation and preventing
septic shock. However, the physiological significance and
clinical relevance of LPS tolerance, especially in the context
of a live bacterial infection, remain in question [4,5]. In
particular, the relevance of polymorphonuclear neutrophils
(PMN) in bacterial clearance is not understood fully in the
tolerant context. Some studies reported an increased clear-
ance of both Gram-positive and -negative organisms after
tolerance induction [6–8]. Nevertheless, it is important to
note that in these studies, bacteria were injected at the same
site of the previous LPS administration, leading to an
increased local influx of leucocytes prior to bacterial
challenge. Therefore, in this study we used two different
anatomical sites for tolerance induction (systemic) and bac-
terial challenge (peritoneal). In order to elucidate the role of
PMN in bacterial clearance, local macrophages were
depleted and focused our study on the analysis of different
PMN bactericidal mechanisms involved in the process of
bacterial clearance.
Neutrophils extracellular trap (NET) formation is a
recently described anti-microbial mechanism of PMN which
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involves the release of chromatin decorated with granular
proteins in order to bind extracellularly and kill microorgan-
isms, respectively [9]. This prompted us to determine the
contribution of this bactericidal mechanism in bacterial
clearance in the tolerant state.
In this study, we found that tolerant animals clear
a polymicrobial infection more efficiently than control
animals. In this process, neither phagocytosis nor produc-
tion of reactive species resulted in significant mechanisms to
explain the mentioned difference. However, a higher PMN
migration towards the infection site, presumably of PMN
from an enhanced marginal pool, may account for this
difference. Remarkably, LPS tolerance causes PMN priming
effects that resulted in higher NET formation as the main
mechanism involved in bacterial clearance.
Materials and methods
LPS tolerance model
BALB/c mice were bred in the animal facility of the Depart-
ment of Experimental Medicine, Academia Nacional de
Medicina, Buenos Aires. Male mice aged 9–16 weeks and
weighing 20–25 g were used throughout the experiments.
They were maintained under a 12-h light–dark cycle at
22  2°C and fed with standard diet and water ad libitum.
The experiments performed were conducted according to
principles set forth in the Guide for the Care and Use of
Laboratory Animals [10]. A scheme of daily intravenous
(i.v.) inoculation of low doses of LPS (Sigma, St Louis, MO,
USA; O111:B4, with 0·41% of protein content assay by the
method of Lowry, as specified by the provider) was per-
formed to render mice tolerant to LPS: days 1 and 2: 5 mg per
mouse and days 3 and 4: 10 mg per mouse. Simultaneously,
another group of mice was injected with the same volume of
saline.
Polymicrobial challenge
The caecum of an untreated mouse was removed and the
intestinal content was left at 37°C for 24 h in saline 10% fetal
calf serum (FCS) in aerobic conditions; 5 ¥ 107 aerobic-
enriched bacteria were injected intraperitoneally (i.p.) to
control and tolerant mice. Routine bacteriological identifi-
cation revealed that bacteria present in the inoculum
belonged to Enterococcus and Streptococcus spp. Four hours
later, blood was obtained and peritoneal lavage was per-
formed with sterile saline solution as described below.
Dosage of bacteria was performed in agar MacConkey plates.
Depletion of peritoneal macrophages
The depletion of peritoneal macrophages was performed
by i.p. inoculation of liposomes loaded with clodronate,
as described previously [11]. Liposomes loaded with
clodronate were prepare as described previously [12,13] and
0·7 mg per mouse was injected.
Blood sample collection and cell count determination
Blood samples were obtained by puncture of the retro-
orbital plexus. A differential count of leucocytes in whole
blood was performed with a Neubauer chamber using Turk’s
solution (0·01% gentian violet in 3% glacial acetic acid) by
light microscopy.
Peritoneal lavage
Animals were killed and the peritoneal content was collected
by peritoneal lavage, as described previously [14]. Briefly, the
skin of the abdomen was cut open in the midline after thor-
ough disinfection and without injuring the muscle. Sterile
saline solution (2 ml) was injected into and aspirated out of
the peritoneal cavity twice, using a sterile syringe and needle,
to rinse out the content from the peritoneal cavity. Cells were
washed and counted as described above for whole blood, and
the peritoneal liquid was used for determination of bacterial
cultures as described below.
Bacterial cultures
Blood and peritoneal lavage was obtained and cells were
lysed with sterile distilled water. Aliquots of serial log
dilutions of peritoneal fluid and blood were plated onto a
selective growth medium for intestinal bacteria, MacConkey
agar (Britania, Buenos Aires, Argentina). Plates were grown
under aerobic conditions at 37°C, and colonies were counted
after overnight incubation. Bacterial counts are expressed
as colony-forming units (CFU) per millilitre of peritoneal
lavage or blood.
In vivo phagocytosis of bacteria
Fluorescein isothiocyanate (FITC)–Escherichia coli conjuga-
tion was performed as described previously [15]. FITC–E.
coli (1 ¥ 107) were injected i.p. After 4 h, peritoneal lavage
was performed and cells were incubated for 2 min with
trypsin/ethylenediamine tetraacetic acid (EDTA) at 37°C (to
release attached but not internalized bacteria). Immediately
afterwards, 10% FCS was added, and after washing, cells were
incubated with phycoerythrin (PE)-conjugated Ly-6G for
30 min at room temperature. Cells were washed and resus-
pended in 0·2 ml of BD FACSflow (BD Bioscience, San Jose,
CA, USA). The percentage of double-positive cells and the
mean fluorescence intensity (MFI) of FITC were measured
by flow cytometry.
Contribution of reactive nitrogen and oxygen species
Ten minutes before bacterial challenge, the inhibitor of
nitric oxide synthase, Nw-nitro-L-arginine methyl ester
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(L-NAME) (1·5 mg per mouse; Sigma), was inoculated i.p.
After 4 h, peritoneal lavage was performed and CFU were
evaluated using MacConkey agar plates. NO production was
determined by measurement of nitrite (in cell-free superna-
tants from peritoneal lavage) using the Griess reaction.
Briefly, 50 ml of sample aliquots were mixed with 50 ml of
Griess reagent (1% sulphanilamide/0·1% naphthylethylene
diamine dihydrochloride/2% phosphoric acid) in 96-well
plates and incubated at 25°C for 10 min. Absorbance at
540 nm was measured with a microplate reader. NaNO2 was
used as standard to calculate nitrite concentrations. To deter-
mine the production of reactive oxygen species (ROS) on
peritoneal migrated PMN, dihydrorhodamine (DHR)-123, a
derivative of rhodamine 123, was used. Briefly, PMN from
the peritoneal lavage (2 ¥ 105) were incubated 15 min at
37°C with 1 mM DHR-123. Immediately afterwards, the
green fluorescence was measured by flow cytometry.
In vitro evaluation of neutrophil extracellular
traps (NETs)
A polymicrobial challenge was performed and 4 h later cells
within the peritoneal cavity were collected. Stimulation of
NETs formation was measured as described previously, with
minor modifications [16]. Briefly, PMN (0·1 ¥ 106) were
seeded gently onto glass coverslips coated with 0·001% polyl-
ysine in a 48-well plate in triplicate, allowed to settle, and
incubated in the presence of phorbol 12-myristate 13-acetate
(PMA, 50 nM). In order to visualize incipient NETs and
quantify accurately the PMN undergoing NETosis we chose
an incubation period of 6 h at 37°C 5% CO2. After the incu-
bation period, samples were gently fixed with 4% paraform-
aldehyde (PFA), then washed with phosphate-buffered saline
(PBS), and the percentage of NET-forming PMN were deter-
mined using epifluorescence microscopy by staining DNA
with propidium iodide. At least 10 different fields were
observed in each triplicate (¥400).
In vivo evaluation of NETs formation
In vivo, NET contribution was determined by i.p. inocula-
tion of microccocal nuclease (mccal, 100 U/mouse, prepared
in PBS ¥1 with 5 mM Cl2Mg and 5 mM Cl2Ca; Worthington,
Lakewood, NJ, USA) or mccal plus EDTA (10 mM) in order
to inactivate mccal activity, 10 min before i.p. bacterial
challenge. After 4 h, peritoneal cells were collected carefully
and seeded gently on polylysine pretreated coverslides. After
fixation with 2% PFA, samples were washed and NETs were
stained with propidium iodide. Images for NETs evaluation
were acquired using a FluoView FV1000 confocal micro-
scope (Olympus, Tokyo, Japan) equipped with a Plapon
60 ¥ /1·42 objective lens and processed using Olympus
FV10-ASW software by considering maximum fluorescence
intensity projections along the whole Z-stack.
Marginal pool cell collection
Marginal pool PMN were obtained as described previously
[17], with modifications. Under anaesthesia peripheral
blood was taken from the retro-orbital plexus (ª1 ml).
Animals were then infused via the heart using a perfusion
buffer consisting of PBS supplemented with 5 mM EDTA to
avoid coagulation and 60 g/l dextran (MW 500 000) to
increase the colloidal osmotic pressure. Simultaneously,
blood was drawn via the retro-orbital plexus. The first 3 ml
were discarded in order to ensure that the majority of
the peripheral blood had been removed. A second sample
was then obtained by further perfusion of 10 ml of perfu-
sion buffer and considered as the marginal pool. Peripheral
blood and marginal pool cells were counted as described
above. Cellular characterization of the marginal pool was
performed by optical microscopy with May–Grünwald–
Giemsa-stained smears.
Peripheral blood PMN isolation
Isolation of PMN from peripheral blood or marginal pool
from individual mice was performed as described previously
[18]. Briefly, PMN cells were obtained by centrifugation on a
Ficoll-Hypaque density gradient (d = 1090; Ficoll Pharma-
cia, Uppsala, Sweden; Hypaque; Wintthrop Products, Buenos
Aires, Argentina) followed by sedimentation in 6% dextran.
Contaminating erythrocytes were removed by hypotonic
lysis. After washing, the cells (>96% PMN on May–
Grünwald–Giemsa-stained preparations) were resuspended
in RPMI medium.
Chemotaxis assay
PMN chemotaxis was quantified using a modification of
the Boyden chamber technique [19]. A cell suspension
(50 ml) containing 2 ¥ 106 cells/ml in RPMI with 0·5%
bovine serum albumin (BSA) was placed into the top wells
of a 48-well microchemotaxis chamber. A polyvinylpyrroli-
done (PVP)-free polycarbonate membrane (3-mm pore
size; Neuro Probe Inc., Gaithersburg, MD, USA) separated
the cells from lower wells containing either RPMI or
N-Formyl-Met-Leu-Phe (fMLP) (10-7 M). The chamber
was incubated for 90 min at 37°C in a 5% CO2 humidified
atmosphere. After incubation, the filter was stained with
Tincion-15 (Biopur SRL, Rosario, Argentina), and the
number of PMN on the undersurface of the filter was
counted in at least five random high-power fields (HPF)
¥400 for each of the triplicate filters.
Statistical analysis
Data are expressed as mean  standard error of individual
mice. For two-group comparison, Student’s t-test was
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applied for normally distributed data (Kolmogorov–
Smirnov normality test), except for non-parametric data
from Figs 1a and 2b, where the Mann–Whitney U-test was
applied. The comparisons between multiple groups were
made by analysis of variance (anova), applying Bonferroni’s
post test. P < 0·05 was considered significant.
Results
Tolerant mice clear polymicrobial challenge more
efficiently in the absence of macrophages
Mice were rendered tolerant by daily i.v. inoculation of low
doses of LPS, and peritoneal macrophages were depleted by
clodronate-loaded liposomes (lip-clod) treatment prior to
an i.p. polymicrobial challenge. The depletion of macroph-
ages within the peritoneal cavity was almost complete, as
verified by staining of peritoneal cells with the specific F4/80
macrophage marker (25% of total cells versus 0·1% after
lip-clod treatment). As depicted in Fig. 1, despite the absence
of macrophages, 4 h after the inoculation of intestinal live
bacteria the remaining CFU were lower in tolerant mice both
in peritoneum (Fig. 1a) and blood (Fig. 1b) compared to
control mice. Although circulating monocytes were not
depleted by the lip-clod treatment, 4 h after the bacterial
challenge few, if any, monocytes were observed within the
peritoneal cavity.
This indicates that tolerant mice are more efficient in
eliminating a bacterial challenge compared to control
animals. More rapid clearance is unlikely, given that the
number of CFU was still lower in tolerant mice at 24 h
post-challenge (data not shown).
In parallel, we found an increase in the absolute number
of PMN that have migrated to the infectious focus (Fig. 1c).
No PMN were observed in the peritoneal cavity before bac-
terial challenge in control or tolerant mice (data not shown).
The decreased remaining CFU in the peritoneum and
the increased number of migrating PMN in tolerant mice
were also observed in the absence of the lip-clod treat-
ment (CFU ¥ 104/ml in peritoneum: control = 1·7  0·4;
tolerant = 0·4  0·1*; PMN in peritoneum ¥ 106: con-





























































Fig. 1. Increased clearance of a polymicrobial challenge in the absence of macrophages in mice tolerant to lipopolysaccharide (LPS).
Colony-forming units (CFU) (5 ¥ 106) of live intestinal bacteria were injected intraperitoneally (i.p.) after depletion of macrophages (by lip-clod
treatment) in control mice and mice rendered tolerant to LPS by intravenous (i.v.) inoculation of LPS (n = 12). After 4 h, CFU were evaluated
in peritoneal lavage (a) and blood (b). (c) The absolute number of total polymorphonuclear neutrophils (PMN) in the peritoneal lavage was
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Fig. 2. Evaluation of in vivo phagocytosis of bacteria. Tolerance was developed by intravenous (i.v.) inoculation of lipopolysaccharide (LPS). Dead
fluorescein isothiocyanate (FITC)–Escherichia coli was injected intraperitoneally (i.p.) in control and tolerant animals and 4 h later peritoneal lavage
was performed (n = 12). The % (a) and mean fluorescence intensity (MFI, c) of FITC + polymorphonuclear neutrophils (PMN) (identified as
Ly-6G+ cells) were determined by flow cytometry. The absolute number of FITC + PMN (b) was calculated using the absolute number of PMN in
the peritoneal lavage and the % of FITC + PMN shown in (a); *P < 0·05 versus control.
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control). Additionally, liposomes per se did not cause migra-
tion of PMN to the peritoneal cavity. These results reveal a
key role of PMN in the resolution of local bacterial challenge,
especially in tolerant mice.
Tolerant mice have increased number of PMN which
phagocyte bacteria
In order to determine further the underlying mechanisms
for the increased bacterial clearance observed in the tolerant
state, the phagocytic ability of PMN was evaluated in situ by
injecting death E. coli conjugated to FITC (FITC–E. coli) in
the peritoneal cavity in macrophage-depleted mice. After
4 h, peritoneal lavage was performed and FITC + PMN (Ly-
6G+) were determined by fluorescence activated cell sorter
(FACS) flow cytometry. As depicted in Fig. 2a, we found that
the percentage of FITC + PMN was decreased in tolerant
animals. However, as an increased absolute number of
migrated PMN were found in tolerant compared to control
mice (number of PMN (¥106): control = 1·5  0·1, toler-
ant = 4·6  0·5*, *P < 0·05). When these absolute values
were use to calculate the number of FITC + PMN, a statisti-
cally significant increase was observed in tolerant mice
(Fig. 2b). No differences in the amount of FITC–E. coli per
individual PMN (MFI) were observed between control and
tolerant PMN (Fig. 2c).
These results indicate that although phagocytosis per se is
not altered in the state of tolerance to LPS, there is a higher
phagocytic index as a result of the increased migration of
PMN at the site of bacterial challenge.
Reactive species do not account for the enhanced
bacterial clearance in tolerant mice
In order to determine the contribution of nitrogen reactive
species to the enhanced clearance, experiments were per-
formed in macrophage-depleted mice by injecting a nitric
oxide synthase (NOS) inhibitor, L-NAME, in the peritoneal
cavity 10 min before bacterial challenge. After 4 h, although
remaining CFU were still statistically lower in the tolerant
group, both control and tolerant mice showed an approxi-
mately fourfold increase in CFU when L-NAME was admin-
istered (Fig. 3). Within each group, the inhibition of NOS
did not affect the migration of PMN to the site of bacterial
inoculation (data not shown). This result indicates that NO
production contributes to the bacterial clearance equally
and, therefore, this mechanism cannot account for the more
efficient clearance observed in tolerant animals.
Additionally, when hydrogen peroxide generation was
evaluated in individual PMN using DHR by FACS in PMN
that have migrated to the peritoneal cavity after the chal-
lenge, no differences were observed in the MFI of DHR in
PMN from control and tolerant mice. As no PMN were
present in the peritoneal cavity before bacterial challenge,
PMN from peripheral blood were used to determine whether
hydrogen peroxide generation in migrated PMN increased
above that of unstimulated PMN. Values obtained for
peripheral blood PMN before challenge were five times
lower than those obtained for migrated PMN after bacterial
challenge (MFI DHR from blood PMN before challenge:
control = 23·4  1·87; n = 10; tolerant = 21·8  1·3, n = 12;
MFI DHR from peritoneal migrated PMN after challenge:
control = 103·5  8·1; n = 10; tolerant = 99·6  5·2, n = 12).
Together, these results suggest that reactive species genera-
tion is not the major mechanism involved in the increased
clearance mediated by PMN in the tolerant state.
Neutrophil extracellular traps are involved in the
enhanced clearance in tolerant mice
In addition to the more traditional mechanism of phago-
cytosis to kill bacteria, activation of PMN causes the release
of DNA structures (NET). We first evaluated the efficiency
of migrated PMN to form NETs in vitro. PMN were col-
lected 4 h after the bacterial challenge and NETs were
induced by incubation with the potent protein kinase C
(PKC) activator phorbol 12-myristate 13-acetate (PMA), as
described previously [16]. After an additional 6 h, the
number of PMN undergoing NETosis was quantified
microscopically. Interestingly, the percentage of NET-
forming PMN was higher in PMN from tolerant compared
to control animals (Fig. 4a).
Moreover, NETs contribution in vivo in tolerant mice



















































Fig. 3. The increased bacterial clearance in tolerant mice is not
affected by inhibition of reactive nitrogen species. In vivo contribution
of reactive nitrogen species production was determined by inoculating
the inhibitor of reactive nitric oxide synthase, Nw-nitro-L-arginine
methyl ester (L-NAME) (1·5 mg per mice) 10 min before bacterial
challenge in control and tolerant mice. After 4 h, colony-forming units
(CFU) were evaluated using agar MacConkey in peritoneal lavage.
The numbers at the top of the bars indicate the fold increase of
CFU/ml + L-NAME versus untreated mice. Inset: nmol of NO2/ml
were determined in the experimental groups by the Griess method;
n = 9, *P < 0·05 versus control, #P < 0·05 versus tolerant, +P < 0·05
versus control + L-NAME.
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to digest chromatin) in the peritoneal cavity 10 min before
bacterial challenge. As depicted in Fig. 4b, mccal treatment
increased the CFU values in tolerant mice reaching control
values, and this effect was reversed when mccal was inacti-
vated by a 5-min preincubation with EDTA immediately
before injection. Although NETs were visualized in PMN
from control mice (Fig. 4c), CFU values were not affected by
mccal treatment. Within each group, mccal treatment did not
modify the migration of PMN to the site of bacterial inocu-
lation (data not shown).
In vivo results were also corroborated by confocal micros-
copy (Fig. 4c–f). Analysis of the microphotography obtained
revealed some interesting aspects. On one hand, and con-
firming in vitro results, PMN from tolerant mice showed
larger amounts of bacteria trapped in NETs (Fig. 4d). On the
other hand, NETs integrity was clearly affected when mccal
was employed (Fig. 4e) and this was reversed by EDTA
preincubation (Fig. 4f).
Taken together, these results indicate clearly that NET for-
mation is crucial for the increased clearance mediated by
PMN in the tolerant state.
Increased PMN in the marginal pool compartment
with higher migratory capacity in tolerant mice
As we have demonstrated previously, an increased number
of PMN arriving to the site of bacterial challenge could be
a critical determinant to the increased clearance observed
in tolerant mice. It is well established that a considerable
number of PMN are retained within the intravascular com-
partment, which is referred commonly as the marginal pool
[20–22]. This marginal pool PMN is thought to be mobilized
promptly immediately after a chemotactic signal. Therefore,
in order to determine whether an increased marginal pool
PMN could account for the increased number of migrated
PMN after bacterial challenge, both the absolute number of
PMN in peripheral blood and within the marginal pool after
tolerance have been established. Figure 5a shows that in spite
of having similar numbers of PMN in circulation, PMN
within the marginal pool were increased in tolerant animals.
In agreement with Klonz et al. [17], the composition of the
marginal pool was constituted by PMN and other cells such
as lymphocytes and monocytes. Optical microscopy exami-
Fig. 4. Enhanced neutrophil extracellular traps
(NETs) formation is involved in the increased
bacterial clearance in tolerant mice. (a) In vitro
NETs formation capacity was evaluated on
polymorphonuclear neutrophils (PMN)
recovered from the peritoneal cavity 4 h after
polymicrobial challenge. PMN were seeded and
treated with phorbol myristate acetate (PMA)
for 6 h. The percentage of PMN-forming NETs
(NETotic PMN) was determined using
epifluorescence microscopy by staining DNA
with propidium iodide; n = 6, *P < 0·05 versus
control. (b) In vivo NET contribution was
determined by inoculating micrococcal nuclease
(mccal) or mccal + ethylenediamine tetraacetic
acid (EDTA) 10 min before bacterial challenge
in control and tolerant mice. Four hours later
colony-forming units (CFU) were evaluated
using agar MacConkey in peritoneal lavage;
n = 13, *P < 0·05 versus control, #P < 0·05 versus
tolerant, +P < 0·05 versus tolerant + mccal.
(c–f) Four hours after the baterial challenge
peritoneal, PMN were carefully collected and
seeded onto coverslides. DNA was stained with
propidium iodide and NETs were visualized by
confocal microscopy (¥200 and insets ¥600).
Asterisks indicate propidium iodide-stained
bacteria. Representative microphotographies of
an independent experiment are shown from
one control (c), tolerant (d), tolerant with
mccal treatment (e) and tolerant with mccal
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nation using May–Grümwald–Giemsa staining revealed a
statistically significant increase in the percentage of PMN
(Fig. 5b and c). Moreover, FACS analysis revealed similar
percentages of double-positive Ly-6G (specific for PMN)
CD11b cells (% Ly-6G+ CD11b+ cells: control = 12·4  0·3;
tolerant = 25·6  2·1*, n = 6, *P < 0·05 versus control). The
expression of CD11b or Ly-6G within Ly-6G+ CD11b+ cells
was similar between marginal and blood PMN (data not
shown).
Additionally, we tested the migratory capacity of PMN
within these two compartments in vitro using fMLP, the
most potent chemotactic factor present in all bacteria. We
found that PMN from the marginal pool of tolerant mice
showed the highest migratory capacity compared to both
control marginal pool and tolerant peripheral PMN
(Fig. 5c).
These results indicate that an increased PMN from
the marginal pool with a higher migratory capacity could
also contribute to the more efficient bacterial clearance in
tolerant state.
Discussion
The means by which the host is able to combat bacterial
infection within the peritoneal cavity has been of interest to
investigators for more than a century. From the outset, it was
clear that bacterial removal and phagocytosis were impor-
tant host defences [23]. During the tolerant state, active
important immune mechanisms are mounted. In this sense,
some studies have reported an increased clearance of both
Gram-positive and -negative organisms after induction
of tolerance to LPS [6,24,25]. The goal in the present study
was to define more precisely the role of PMN in host defence
in tolerant mice and to determine the role of some of
the most relevant PMN bactericidal components in bacterial
clearance during experimental peritonitis. Our experiments
were conducted using two different anatomical sites for
LPS administration to induce tolerance and for bacterial
challenge. As PMN are the first cells arriving at the site of
infection, an advantage of this experimental setting is that,
focusing on early phases of the induced peritonitis, it allows
to study the relevance of the migration process of PMN
itself. Additionally, different critical steps of PMN bacteri-
cidal mechanisms can also be evaluated by local administra-
tion of inhibitory factors, determining the precise impact of
these mechanisms on bacterial clearance.
Although both PMN and macrophages are crucial
for the resolution of an infection, the functional state of












































































Fig. 5. The marginal pool of polymorphonuclear neutrophils (PMN)
is increased in tolerant mice. (a) The absolute number of PMN
present in peripheral blood and marginal pool were determined as
described in Materials and methods; n = 18, *P < 0·05 versus control
marginal pool. (b) Cellular composition of the marginal pool as
determined by light microscopy using May–Grünwald–Giemsa
staining; n = 6, *P < 0·05 versus control. †Very large cells that could
not be assigned to any category. (c) In vitro chemotactic migration of
PMN against N-Formyl-Met-Leu-Phe (fMLP). Isolated PMN from
peripheral blood and marginal pool (1 ¥ 105) were allowed to migrate
through a polycarbonate filter for 90 min at 37°C with CO2 in
response to fMLP (10-7 M). Then, the filter was fixed and stained and
the number of chemotactic cells was counted in five random
high-power fields (¥400) for each of triplicate samples. The results
were expressed as the number of migrated PMN per field; n = 6
*P < 0·05 versus control marginal pool and peripheral blood, #P < 0·05
versus tolerant peripheral blood.

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widely both in vivo and in vitro [26–28]. However, the rel-
evance of the bactericidal capacity of PMN in this context
has been less explored. Therefore, in order to elucidate the
actual contribution of PMN, by depleting peritoneal mac-
rophages with clodronate-loaded liposomes, we created a
system where the contribution of macrophages does not
mask the results of the phenomena we want to study. We
demonstrated that the clearance of a polymicrobial challenge
was highly efficient in the tolerant state, even in the absence
of macrophages. This could not be attributed to a higher
phagocytic capacity of migrated PMN per se, or a higher
leakage of bacteria to the peripheral blood. Our results are
in line with the finding of Murphey et al., who found that
the increased clearance of Gram-positive bacteria in tole-
rant mice was not related to differences in their phagocytic
activity [29].
PMN migration to infectious foci is extremely important
for the local control of bacterial growth and consequently
for the prevention of bacterial dissemination. It has been
shown that the failure of PMN to migrate to the infection site
in lethal sepsis is accompanied by an increased number of
bacteria in the peritoneal fluid and in the circulation and
by a high mortality rate of the host [30,31]. We found an
increased number of PMN that have migrated to the perito-
neal cavity, the site of bacterial challenge. Enhanced PMN
migration in the tolerant state was observed both in the
presence or absence of macrophages, thus indicating that
the signals secreted from resident activated peritoneal
macrophages may not be determinant for attracting PMN in
a context of high chemotactic bacterial factors. Additionally,
the number of migrated PMN was higher when macro-
phages were depleted, even though the remaining bacteria
(CFU/ml) were similar, suggesting compensatory migratory
mechanisms in order to achieve a similar outcome. As it has
been theorized that cells from the marginal pool are mobi-
lized more readily in response to infections, the higher
number of PMN within the marginal pool, together with the
observed increased chemotactic activity towards fMLP in
vitro of PMN from the marginal pool, may explain the
increased number of cells at the infectious site after bacterial
challenge in tolerant mice. Therefore, LPS priming leads not
only to a redistribution of these PMN within the body, but
also sets up mechanisms allowing a quick response when a
danger signal arrives on the scene. Our results may contra-
dict what has been described in severe septic patients. It has
been shown that PMN from patients displayed a marked
reduction in their chemotactic response compared with
PMN from healthy subjects [32]. However, this discrepancy
may be due to the fact that migration assays in patients were
conducted using blood PMN, which may represent a differ-
ent population than the one that first responded to the septic
stimulus. Taking our results into account, it can be hypoth-
esized that early LPS exposure causes priming or activation
of PMN that become part of the marginal pool and are
delivered rapidly to infected tissues, leaving less responsive
(or deranged) cells in the peripheral circulation, accounting
for two different populations of PMN with distinct
responses. This phenomenon, known as compartmentaliza-
tion, implies that the immune status of leucocytes within
inflammatory foci displays a different status than the cells
isolated from the bloodstream, and has been demonstrated
in both experimental animal models and human volunteers
for lung versus blood PMN. In this sense, Abraham et al.
clearly demonstrated in murine models of endotoxaemia
and haemorrhagic shock that lung-derived PMN displayed
activation of transcriptional regulatory factors and increased
expression of inflammatory cytokines, not observed in blood
PMN [33,34]. Additionally, Coldren et al. reported that air
space and circulating PMN showed a different gene expres-
sion pattern when human volunteers were exposed to LPS by
bronchoscopic instillation [35]. In our study, a similar type
of compartmentalization can be proposed between blood
versus marginal pool PMN in tolerant mice. Studies com-
paring the expression of typical adhesion molecules or
functional response in normal rats could not address any
differences between blood versus marginal pool PMN
[17,36]. However, it is possible that even though the func-
tional capacities of cells from the circulating or marginated
pools should be identical in normal conditions, activating/
priming stimuli (such as LPS or soluble factors generated in
response to it) may trigger the mechanisms necessary to
bring out differences between PMN from these two com-
partments, as observed here. To test this hypothesis, we are
now exploring the expression of different chemotactic recep-
tors and making a functional comparative study between
marginal pool and blood PMN in tolerant mice.
The contribution of two other key microbicidal mecha-
nisms was explored in this study: the generation of reactive
species and NET formation. When nitrogen reactive species
generation was blocked in vivo before bacterial challenge,
both tolerant and control mice decreased bacterial clearance
equally. These results reveal that tolerance to LPS failed to
trigger any effect in priming this particular bactericidal
mechanism and eventually, although still relevant to clear
the infection, does not contribute to the enhanced clearance
observed in tolerant mice. It is important to note that, in our
conditions, the number of PMN arriving to the peritoneum
was still augmented in tolerant mice after blockade of nitric
oxide generation, suggesting that LPS effects on marginal
pool PMN regarding migratory capacity may not be regu-
lated by nitrogen-derived reactive species.
NETs play an important role in innate immunity to
microbial infections. NETs have been described in several
species, and their role in infection has not been addressed in
vivo, partly because of the lack of optimal experimental
models. In this sense, we develop a novel tool to investigate
not only NET formation but also their relevance at the site of
an active infection. We found that disruption of NETs by
microccocal nuclease abolished the increased clearance
observed in tolerant animals reaching the amounts of bac-
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teria found in control mice, without affecting directly the
number of PMN that migrate to the peritoneum. Unexpect-
edly, the disruption of NETs in control mice did not modify
bacterial clearance. In this regard, our in vitro results and
those described by others [37] indicate that only a small
percentage of murine PMN undergo NETosis after PMA
stimulation (20–30%). Therefore, under normal conditions
the final outcome after abolishing NETs may not be affected.
In this sense, it is possible that the impact of this mechanism
in bacterial clearance would be similar to other microbicidal
mechanisms (i.e. phagocytosis, ROS generation) and, there-
fore, the relevance of NETs becomes more evident in a
primed (tolerant) context where the clearance of bacteria
must be optimized. In line with this hypothesis, the NETs
visualized from tolerant mice seemed to bind greater
amounts of bacteria than NETs from control PMN, suggest-
ing that NETs in tolerant PMN may also be more functional.
In this sense, LPS priming may somehow favours the
NETotic pathway over other mechanisms to eliminate an
infection. In line with this, others have proposed that PMN
undergo NETosis rather than the more classical phagocytosis
to sieze bacteria under stressful conditions [38]. Therefore,
tolerance to LPS can be considered a putative scenario where
this kind of hierarchy of bactericidal mechanisms occurs.
Moreover, the efficiency of PMN to undergo NETosis was
also increased in the tolerant context, as revealed using PMA,
indicating that not only a higher number of migrated PMN,
leading to an increase number of NETs, but also intrinsic
differences in the ability of individual PMN to form NETs,
account for the increased bacterial clearance in tolerant
mice. These results highlight the contribution of NETosis as
a key active mechanism for in vivo resolution of infections in
the tolerance to LPS state.
It has been described that NETs are dependent upon ROS
generation after PMN activation [16,37]. Moreover, NET
formation has been correlated with the amount of ROS pro-
duced [37]. In our study we cannot attribute the higher
NET-forming capacity of PMN from tolerant mice to a con-
comitant higher generation of ROS, as the amount of H2O2
per peritoneal PMN from control and tolerant mice was
similar. This reveals that, independently of the amount of
ROS triggered, LPS tolerance may be favouring the forma-
tion of NETs by other mechanisms, which are currently
being investigated. Considering that chemokines (and prob-
ably other unknown factors) can also induce NETs [9,39],
ongoing studies will address whether bacterial challenge trig-
gers a higher local (peritoneal) chemotactic response in tol-
erant mice that can explain the observed higher induction
of NETs.
In summary, the higher number of PMN arriving at the
site of bacterial challenge, presumably coming from the mar-
ginal pool with an increased chemotactic response, together
with an enhanced NET-forming ability of the migrated
PMN, as demonstrated in vitro, seem to be the main mecha-
nisms accounting for a more efficient prevention of bacterial
spreading in the state of tolerance. These interesting results
open a wide field for elucidating the relevance of marginal
pool PMN function in the context of infections and the
regulating mechanism conferred by LPS priming. There is
evidence that indicate that LPS tolerance can also cause
immunosuppression in mice. Lu et al. have demonstrated
that the inoculation of a pathogenic strain of E. coli causes
30% mortality in LPS-primed mice versus 0% in PBS-
primed mice [40]. We have also observed a state of immu-
nosuppression after LPS tolerance that involves only
adaptive responses, such as T cell proliferation and antibody
production [41]. Moreover, LPS-immunosuppressed mice
survived a lethal dose of intestinal bacteria (three times
higher than the one used in this manuscript) compares to
control mice that died within 24 h (100% survival in LPS
versus 0% survival in control mice). In this sense, we believe
that LPS priming of PMN mechanisms involved in the
increased bacterial clearance in tolerant mice may be trig-
gered in an attempt to compensate the deficiencies observed
in the adaptive immune response. In line with this proposi-
tion, Parker et al. have shown that LPS induce a priming,
rather than a tolerant effect, on human PMN [42].
Finally, as tolerance has been postulated as a protective
mechanism limiting excessive inflammation and preventing
septic shock, our results suggest that LPS exposure can
induce PMN priming effects which may favour distant anti-
infectious responses.
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